New JCI Publication: Murine study of GVAX + a hmab in breast cancer supporting John Hopkins Ph2 clinical trial of GVAX + Herceptin in HER2/new breast cancer (which is also targeted by Neuvenge). Discussion at: <a href="http://www1.investorvillage.com/smbd.asp?mb=247&mn=403&pt=msg&mid=4541063" target="_blank">http://www1.investorvillage.com/smbd.asp?mb=247&mn=403&pt=msg&mid=4541063</a>